Almirall (OTCMKTS:LBTSF) Shares Down 3.5% – Should You Sell?

Almirall, S.A. (OTCMKTS:LBTSFGet Free Report)’s share price fell 3.5% on Friday . The company traded as low as $9.17 and last traded at $9.17. 312 shares were traded during trading, an increase of 56% from the average session volume of 200 shares. The stock had previously closed at $9.51.

Almirall Stock Performance

The stock’s 50 day moving average price is $9.51 and its two-hundred day moving average price is $9.51.

Almirall Company Profile

(Get Free Report)

Almirall, SA, a biopharmaceutical company, engages in the purchase, manufacture, storage, and sale of skin-health medicines in Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising actinic keratosis, atopic dermatitis, alopecia areata, skin cancer, psoriasis, onychomycosis, vitiligo, hidradenitis suppurativa, oncodermatology, acne, orphan indications, and rare skin diseases, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, respiratory, and nervous system; dermatologicals; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations.

Recommended Stories

Receive News & Ratings for Almirall Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Almirall and related companies with MarketBeat.com's FREE daily email newsletter.